Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE.
Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE. Mult Scler. 2015 Jul; 21(8):1025-35.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Disability Evaluation
Disease Progression
Double-Blind Method
Female
Humans
Injections, Subcutaneous
Interferon-beta
Male
Middle Aged
Multiple Sclerosis, Relapsing-Remitting
Polyethylene Glycols
Recurrence
Treatment Outcome
Young Adult